Fusion Genes
Total genes included in the targeted RNA Fusion NGS Panel.
For laboratories with an established DNA testing solution, the RNA Fusion NGS Panel provides a complementary, standalone workflow for detecting fusion events and other transcript-level alterations.
The panel supports detection of known and novel fusion events without requiring both fusion partners or the precise breakpoint to be predefined.
Review the panel’s complete gene content and tier classification to determine how it fits your laboratory’s RNA testing workflow.
Total genes included in the targeted RNA Fusion NGS Panel.
Genes included within the panel’s Tier 1 and Tier 2 content.
Genes included within the panel’s Tier 3 and Tier 4 content.
Extend your laboratory’s testing capabilities while preserving the DNA workflow you already have in place.
Add RNA fusion analysis while maintaining your laboratory’s existing DNA testing workflow.
Detect established fusion events while supporting identification of rare or previously uncharacterized fusion partners.
Identify fusion events without requiring both partners or exact breakpoint locations to be programmed into the assay beforehand.
Expand beyond fusion detection with support for additional transcript-level alterations.
Analyze multiple types of RNA alterations relevant to oncology research and molecular profiling.
Detection of established, rare, and novel fusion events.
Identification of alternative transcript-splicing events.
Detection of transcript alterations involving omitted exons.
Analysis of single-nucleotide variants and small insertions or deletions detected at the RNA level.
Assessment of gene-expression changes within the panel’s targeted content.
Conventional targeted fusion assays may be designed to detect only specific gene pairings or previously established breakpoint locations.
The RNA Fusion NGS Panel uses a partner-agnostic approach that does not require both fusion partners or the exact breakpoint to be predefined.
This supports broader detection of known, rare, and novel fusion events while reducing dependence on a fixed list of expected fusion combinations.
DNA and RNA analysis provide different views of tumor biology. The standalone RNA Fusion NGS Panel allows laboratories to add transcript-level analysis without replacing an existing DNA mutation panel.
Laboratories with an established DNA NGS workflow seeking to add complementary RNA analysis.
Laboratories expanding their oncology testing capabilities to include fusion and transcript-level analysis.
Laboratories developing broader tumor-profiling menus across multiple oncology applications.
Laboratories studying fusion events and other RNA-level alterations.
Programs that want to preserve their current DNA assay while adding a separate RNA workflow.
Laboratories seeking focused RNA analysis as an alternative to broader RNA-sequencing approaches.
Interested in adding standalone RNA fusion analysis to your existing DNA workflow?
Complete the form to request panel specifications, gene content, specimen requirements, pricing, or implementation information.
A Jant representative will contact you to discuss your laboratory’s current workflow and RNA testing needs.